DEFA14A ·Filed Apr 20, 2026
Proxy solicitation materials
Actionable Insight • Neutral
Monitor for any unexpected director nominations or shareholder proposals in future filings, but this routine proxy statement has no immediate trading implications.
Final — all horizons settled through T+60d
AURA ▼ -7.39% at T+60d
NEUTRAL call -7.39% · α vs SPY -14.29% · entry $7.44 → $6.89
T+1d
+0.67%
call +0.67% · α -0.35%
$7.49
settled 6mo ago
T+5d
-6.45%
call -6.45% · α -7.54%
$6.96
settled 6mo ago
T+20d
+0.40%
call +0.40% · α -4.51%
$7.47
settled 5mo ago
T+60d
-7.39%
call -7.39% · α -14.29%
$6.89
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
Aura Biosciences is holding its 2026 Annual Meeting where shareholders will vote to elect two Class II directors and ratify Ernst & Young LLP as the independent auditor. This is a routine governance filing with no material financial or strategic implications.
Key Financial Metrics
Vote
director election
Meeting
2026-06-11
Seats Contested
2
Key Facts
- Shareholders will vote to elect two Class II directors: David Johnson and Teresa Marie Bitetti
- Shareholders will vote to ratify Ernst & Young LLP as the independent registered public accounting firm for 2026
- The annual meeting will be held virtually on June 11, 2026
Financial Impact
No direct financial impact
Risk Factors
- None identified in this filing
Market Snapshot
Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-164016 |
| Document: 0001193125-26-164016-index-headers.html | 0001193125-26-164016 |
| Document: 0001193125-26-164016-index.html | 0001193125-26-164016 |
| Document: 0001193125-26-164016.txt | 0001193125-26-164016 |
16 reports for AURA
89% Hit rate @ T+20 Went positive at some point 9 of 9 best @ T+20▲ +18.46%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 22, 2026 5w ago | Institutional Cluster | $6.45 $6.56 | ▲ +1.71% | ▲ +2.27% | $6.18 (−4.19%) |
Aug 21, 2026 9w ago | EFFECT | $7.80 $6.36 | ▲ +18.46% | ▲ +17.94% | $6.18 (+20.77%) |
Aug 11, 2026 11w ago | 8-K | $8.04 $7.20 | ▲ +10.45% | ▲ +9.39% | $6.18 (+23.13%) |
Aug 11, 2026 11w ago | Press Release | $8.04 $7.20 | ▲ +10.45% | ▲ +9.39% | $6.18 (+23.13%) |
Jul 8, 2026 15w ago | 8-K | $7.25 $7.18 | ▼ −0.97% | ▼ −4.24% | $6.18 (−14.76%) |
May 19, 2026 23w ago | Press Release | $7.47 $6.34 | ▼ −15.13% | ▼ −15.87% | $6.18 (−17.27%) |
May 5, 2026 25w ago | 8-K | $8.29 $6.88 | ▲ +17.01% | ▲ +19.79% | $6.18 (+25.45%) |
May 5, 2026 25w ago | Press Release | $8.29 $6.88 | ▲ +17.01% | ▲ +19.79% | $6.18 (+25.45%) |
May 4, 2026 25w ago | 8-K | $8.90 $6.90 | ▼ −22.47% | ▼ −27.43% | $6.18 (−30.56%) |
May 4, 2026 25w ago | Press Release | $8.35 $7.19 | ▲ +13.89% | ▲ +19.54% | $6.18 (+25.99%) |
Showing 10 of 16
US Market Status
Market Closed — Opens Thu (12h 12m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers